Logo image of JRJC

CHINA FINANCE ONLINE CO-ADR (JRJC) Stock Analyst Earnings Estimates

NASDAQ:JRJC - Nasdaq - ADR

3.99  -2.45 (-38.04%)

After market: 4.15 +0.16 (+4.01%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020
Revenue
YoY % growth
JRJC revenue by date.JRJC revenue by date.
45.5M
6.81%
35.5M
-21.98%
40M
12.68%
EBITDA
YoY % growth
JRJC ebitda by date.JRJC ebitda by date.
-19.9M
47.48%
-10.89M
45.28%
-10.07M
7.53%
EBIT
YoY % growth
JRJC ebit by date.JRJC ebit by date.
-21.6M
46.00%
-12.1M
43.98%
-11.2M
7.44%
Operating Margin
JRJC operating margin by date.JRJC operating margin by date.
-47.47%-34.08%-28.00%
EPS
YoY % growth
JRJC eps by date.JRJC eps by date.
N/AN/AN/A

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
JRJC Yearly EPS VS EstimatesJRJC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q2 2021
Q2Q % growth
14.809M
51.89%
%
Q4 2020
Q2Q % growth
9.75M
12.20%
%
Q3 2020
Q2Q % growth
10.7M
32.92%
%
Q2 2020
Q2Q % growth
9.75M
9.18%
%
Q1 2020
Q2Q % growth
9.84M
-0.20%
%
JRJC Yearly Revenue VS EstimatesJRJC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A